Techno Trends
TechnoTrends provide comprehensive coverage of the innovations and inventions in pharma products and pharma technologies across the world. The up-to-date listing of latest pharmaceutical product news and technology trends in the global pharma industry, keeps you abreast with all the latest pharmaceutical innovations happening world over.
89bio Discovered Novel Pegozafermin for Nonalcoholic Steatohepatitis
Pegozafermin stands out as a leading analog of fibroblast growth factor 21 (FGF21) and offers several advantages, including robust histological data, exceptional tolerability, and convenient dosing...
Kansas City University Discovered New Cancer Treatment
Researchers at Kansas City University have made a breakthrough in treating pancreatic cancer by repurposing the FDA-approved drug Acipimox, originally designed to treat hyperlipidaemia....
University of Michigan Discovered New Machine-learning Algorithms for Antibodies
Researchers at the University of Michigan have developed a novel machine learning model, led by Tessier's team, aimed at enhancing the design of antibody-based medicines....
Syracuse University Discovered Breakthrough Peptide Therapy for Diabetes
This innovative peptide engages with various gut receptors, triggering the secretion of hormones with crucial roles in regulating blood sugar levels. These hormones work to normalise blood sugar, which is a fundamental aspect of managing diabetes....
Breakthrough Nanoneedle Technology Introduced for Cancer Treatment
The research conducted by the team from Monash University's Institute of Pharmaceutical Sciences (MIPS) and Deakin University's School of Medicine represents a groundbreaking advancement in the field of cancer immunotherapy, particularly in CAR-T cell therapy....
Daiichi Sankyo Discovered Novel ENHERTU® for Patients with Multiple HER2 Expressing Cancers
Daiichi Sankyo has discovered novel ENHERTU®, designed to address the treatment needs of adult patients facing unresectable or metastatic HER2 positive solid tumours that have progressed despite previous treatment and who have exhausted other viable treatment options....
Janssen Pharmaceuticals Introduces Novel TALVEY® for the Tretament of Relapsed And Refractory Multiple Myeloma
Janssen Pharmaceuticals, a subsidiary of Johnson & Johnson, has introduced a new treatment TALVEY® (talquetamab) for patients with relapsed and refractory multiple myeloma....
Mysthera Therapeutics Develops First-in-Class Autoimmune Disease Therapies
They focus on PIM kinases, which play a vital role in multiple immune cell types, like B and T cells, triggering excessive inflammation. Elevated PIM kinase levels may also contribute to the formation of tertiary lymphoid structures (TLS), linked to disease severity and progression....
Zai Lab Introduced Breakthrough Repotrectinib Treatment for Advanced Solid Tumours in China
Zai Lab has introduced a new drug called repotrectinib to help patients with advanced solid tumours that have specific gene mutations (NTRK gene fusions) and have already been treated with other targeted therapies....
RefleXion Medical Developed First-of-its-Kind SCINTIX Biology-guided Radiotherapy
RefleXion Medical has achieved a significant milestone by successfully treating a patient using groundbreaking SCINTIX™ biology-guided radiotherapy....
